HORMONE BINDING GLOBULIN LEVELS IN PATIENTS WITH HEREDITARY ANGIOOEDEMA DURING TREATMENT WITH DANAZOL *

Clinical Endocrinology - Tập 14 Số 6 - Trang 563-570 - 1981
S. Schwarz1, G Tappeiner1, Helmut Hintner1
1Institute of General and Experimental Pathology and Department of Dermatology, University of Innsbruck, School of Medicine, Innsbruck, Austria

Tóm tắt

SUMMARYFive patients with hereditary angiooedema were treated with Danazol for periods up to 10 months. This therapy resulted in normalization of serum levels of the inhibitor of the first complement component and disappearance of clinical disease symptoms in all patients. Although a variety of hormones were measured, only those of the pituitary‐gonadal axis altered during treatment: a moderate decrease in leuteinizing hormone levels and a sharp fall of testosterone in adult men were observed. In all patients, however, both sex hormone binding globulin and thyroxine binding globulin concentrations were considerably suppressed during Danazol therapy. However, levels of corticosterone binding globulin remained unchanged. The fraction of endogenous testosterone not bound to sex hormone binding globulin invariably increased. The possible relevance of these findings to the understanding of the mode of action of Danazol both in these patients and in general, are discussed.

Từ khóa


Tài liệu tham khảo

10.1111/j.1365-2265.1974.tb03298.x

10.1016/S0015-0282(16)42732-9

10.1016/S0015-0282(16)43820-3

10.1210/jcem-32-2-232

10.1016/0002-9378(80)90665-1

10.1095/biolreprod21.1.27

Donaldson V.H., 1977, Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma, Transactions of the Association of American Physicians, 90, 174

10.1111/j.1365-2265.1979.tb03031.x

10.1016/0039-128X(72)90005-0

10.1016/S0015-0282(16)42733-0

10.7326/0003-4819-84-5-580

10.1056/NEJM197612232952602

Heyns W., 1977, The steroid binding β‐globulin of human plasma, Advances in Steroid Biochemistry and Pharmacology., 6, 59

Hintner H., 1979, Danazol treatment of hereditary angioneurotic oedema. Deutsche Medizinische Wochenschrift, 36, 1269–1273. Horn, K., Kubiczek, T., Pickardt, C.R. & Scriba, P.C. (1977) Thyroxine binding globulin (TBG): preparation, radioimmunoassay and clinical significance, Klinische Wochenschrift, 55, 881

10.1126/science.173.3996.553

10.1111/j.1749-6632.1949.tb27297.x

Schwarz S., 1978, Standardized protocol for radioimmunoassay evaluation and quality control, Wiener Klinische Wochenschrift, 90, 781

10.1016/0022-4731(79)90363-7

Schwarz S., 1980, Radioimmunoassay evaluation and quality control by use of a simple computer program for a low cost desk lop calculator, Journal of Clinical Chemistry and Clinical Biochemistry, 18, 215

Shane J.M., 1977, Pituitary gonadotropin responsiveness with Danazol, Fertility and Sterility., 29, 637, 10.1016/S0015-0282(16)43336-4

10.7326/0003-4819-53-4-739

Spooner J.B., 1977, Classification of side effects to Danazol therapy, Journal of International Medical Research, 5, 15

10.1111/j.1365-2133.1979.tb05562.x

10.1016/0010-7824(74)90099-7

10.1210/jcem-43-1-244

Wagner R.K., 1978, Extracellular and intracellular steroid binding proteins, Acta Endocrinologica (Kbh.), 218, 1

Walker W.H.C., 1977, An approach to immunoassay, Clinical Chemistry, 23, 384, 10.1093/clinchem/23.2.384

10.1016/0039-128X(78)90113-7

Wynn V., 1977, Metabolic effects of Danazol, Journal of International Medical Research, 5, 25